Liraglutide ameliorates myocardial damage in experimental diabetic rats by inhibiting pyroptosis via Sirt1/AMPK signaling

Objective(s): Liraglutide, a well-established drug for treating diabetes mellitus (DM), has recently gained attention for its cardiovascular benefits in diabetes via multiple cellular activities; however, whether liraglutide improves myocardial damage by inhibiting pyroptosis and the mechanisms of t...

Full description

Bibliographic Details
Main Authors: Zhe Zhang, Xing Wang, Linlin Yang, Linquan Yang, Huijuan Ma
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2021-10-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Online Access:https://ijbms.mums.ac.ir/article_18784_3d56f1313b5153e99147ee560768fe83.pdf